Results 151 to 160 of about 2,882,240 (203)

Comparative effectiveness and safety of integrase strand transfer inhibitor (INSTI)-based versus non-INSTI-based antiretroviral regimens in treatment-naïve people with HIV: A real-world retrospective cohort study. [PDF]

Medicine (Baltimore)
Ye X, Han J, Zhang Y, Yang C, Zuo Z, Huang L, Hu L, Lei J, Wang M, Cui H, Chen X.   +10 more
europepmc   +1 more source

Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. [PDF]

Clin Infect Dis
Rogg L, Underwood M, Hanan N, Castillo-Mancilla JR, Kahl L, Halliday F, Ghita GL, Jeffrey JL, Byrne S, Onodera T, Horton J, Gartland M.   +11 more
europepmc   +1 more source

Noninvasive Markers of Hepatic Steatosis and Fibrosis Following Integrase Strand-Transfer Inhibitor Initiation in Women With HIV. [PDF]

Clin Infect Dis
Yu MA, Gerig L, Mehta CC, Musonge-Effoe J, Alvarez JA, Ofotokun I, Sheth AN, Ali MK, Ziegler TR, Yang Q, Spence AB, Alcaide ML, Dumond JB, Abraham AG, French AL, Augenbraun M, Anastos K, Price JC, Tien PC, Lahiri CD.   +19 more
europepmc   +1 more source

Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras. [PDF]

Clin Infect Dis, 2023
Jacob JS, Shaikh A, Goli K, Rich NE, Benhammou JN, Ahmed A, Kim D, Rana A, Goss JA, Naggie S, Lee TH, Kanwal F, Cholankeril G.   +12 more
europepmc   +1 more source

Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis. [PDF]

Clin Infect Dis
Perez Navarro A, Nutt CT, Siedner MJ, McCluskey SM, McCluskey SM, Hill A.   +5 more
europepmc   +1 more source

High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy. [PDF]

AIDS, 2022
Huik K, Hill S, George J, Pau A, Kuriakose S, Lange CM, Dee N, Stoll P, Khan M, Rehman T, Rehm CA, Dewar R, Grossman Z, Maldarelli F.   +13 more
europepmc   +1 more source

Metabolomic Profile of Weight Gain of People Living with HIV Treated with Integrase Strand Transfer Inhibitor Regimens Reveals Dysregulated Lipid Metabolism and Mitochondrial Dysfunction. [PDF]

Metabolites
Ascencio-Anastacio AM, Larios-Serrato V, Mata-Marín JA, Rodríguez Evaristo M, Núñez-Armendáriz M, Cano-Díaz AL, Chaparro-Sánchez A, Salinas-Velázquez GE, Maldonado-Rodríguez A, Torres J, García-Flores MM, Martínez-Valencia ZE, Arroyo-Sánchez BI, Olin-Sandoval V, Minauro F, Gaytán-Martínez JE, Pompa-Mera EN.   +16 more
europepmc   +1 more source

Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir. [PDF]

J Antimicrob Chemother
D'Antoni ML, Falkard B, Andreatta K, Cox S, Cohen C, Callebaut C.   +5 more
europepmc   +1 more source

Prevalence of integrase strand transfer inhibitor resistance in people living with HIV and virological failure. [PDF]

J Chin Med Assoc
Tsai HC, Chen IT, Chang HM, Tseng YT, Weng YW, Chen YS.   +5 more
europepmc   +1 more source

Association between integrase strand transfer inhibitor (INSTIs) use with insulin resistance and incident diabetes mellitus in persons living with HIV: A systematic review and meta-analysis protocol. [PDF]

PLoS One, 2022
Mulindwa F, Kamal H, Castelnuovo B, Bollinger RC, Schwarz JM, Brussealers N.   +5 more
europepmc   +1 more source